Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Other Working Capital Changes: 2012-2025

Historic Other Working Capital Changes for Ptc Therapeutics (PTCT) over the last 13 years, with Sep 2025 value amounting to $1.7 million.

  • Ptc Therapeutics' Other Working Capital Changes rose 120.56% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.1 million, marking a year-over-year increase of 759.52%. This contributed to the annual value of -$98.8 million for FY2024, which is 319.51% down from last year.
  • Per Ptc Therapeutics' latest filing, its Other Working Capital Changes stood at $1.7 million for Q3 2025, which was up 139.67% from -$4.2 million recorded in Q2 2025.
  • In the past 5 years, Ptc Therapeutics' Other Working Capital Changes ranged from a high of $104.5 million in Q4 2023 and a low of -$93.9 million during Q1 2024.
  • Over the past 3 years, Ptc Therapeutics' median Other Working Capital Changes value was -$4.2 million (recorded in 2025), while the average stood at -$3.6 million.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first tumbled by 333.78% in 2021, then skyrocketed by 19,843.18% in 2022.
  • Ptc Therapeutics' Other Working Capital Changes (Quarterly) stood at $23.5 million in 2021, then slumped by 31.81% to $16.0 million in 2022, then surged by 552.62% to $104.5 million in 2023, then tumbled by 91.20% to $9.2 million in 2024, then surged by 120.56% to $1.7 million in 2025.
  • Its last three reported values are $1.7 million in Q3 2025, -$4.2 million for Q2 2025, and $16.4 million during Q1 2025.